Dirk Kohlmueller

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

David McHugh, Cynthia A. Cameron, José E. Abdenur et al. · Genetics in Medicine · 2011 · 349 citations · Full text

Metabolic Syndrome, Newborn Screening, Metabolic Disorder +10

Five years of experience with biochemical cystic fibrosis newborn screening based on IRT/PAP in Germany

Olaf Sommerburg, J. Hammermann, Martin Lindner et al. · Pediatric Pulmonology · 2015 · 76 citations

Postnatal Changes in Neonatal Acylcarnitine Profile

Jochen Meyburg, Andreas Schulze, Dirk Kohlmueller et al. · Pediatric Research · 2001 · 73 citations · Full text

Neonatal Acylcarnitine Profile, Neonatology, Physiology +4

Sensitivity of electrospray-tandem mass spectrometry using the phenylalanine/tyrosine-ratio for differential diagnosis of hyperphenylalaninemia in neonates

Andreas Schulze, Dirk Kohlmueller, Ertan Mayatepek · Clinica Chimica Acta · 1999 · 61 citations

Engineering, Electrospray-tandem Mass Spectrometry, Biochemistry +13

Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis‐associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population

Olaf Sommerburg, Martin Lindner, Martina U. Muckenthaler et al. · Journal of Inherited Metabolic Disease · 2010 · 47 citations